Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT). (Q44193416)
Jump to navigation
Jump to search
scientific article published in November 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT). |
scientific article published in November 2002 |
Statements
1 reference
Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT). (English)
1 reference
1 reference
Robert M Califf
1 reference
A Michael Lincoff
1 reference
James E Tcheng
1 reference
Craig Balog
1 reference
M Ashequl Islam
1 reference
James C Blankenship
1 reference
Elias A Iliadis
1 reference
EPISTENT Investigators
1 reference
1 November 2002
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference